Literature DB >> 356868

The influence of acetylator phenotype on the outcome of treatment with phenelzine, in a clinical trial.

E F Marshall, C Q Mountjoy, I C Campbell, R F Garside, I M Leitch, M Roth.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 356868      PMCID: PMC1429446          DOI: 10.1111/j.1365-2125.1978.tb04593.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  11 in total

1.  THE INFLUENCE OF ACETYLATOR PHENOTYPE ON THE EFFECTS OF TREATING DEPRESSION WITH PHENELZINE.

Authors:  D A EVANS; K DAVISON; R T PRATT
Journal:  Clin Pharmacol Ther       Date:  1965 Jul-Aug       Impact factor: 6.875

2.  Determination of 3-methoxy-4-hydroxymandelic acid in urine.

Authors:  J J PISANO; J R CROUT; D ABRAHAM
Journal:  Clin Chim Acta       Date:  1962-03       Impact factor: 3.786

3.  The myth of phenelzine acetylation.

Authors:  E F Marshall
Journal:  Br Med J       Date:  1976-10-02

4.  Phenelzine, mood response, and sleep.

Authors:  D L Dunleavy; I Oswald
Journal:  Arch Gen Psychiatry       Date:  1973-03

5.  Simplified method for determining acetylator phenotype.

Authors:  H Schröder
Journal:  Br Med J       Date:  1972-08-26

6.  Effects of drugs on human blood platelet and plasma amine oxidase activity in vitro and in vivo.

Authors:  D S Robinson; W Lovenberg; H Keiser; A Sjoerdsma
Journal:  Biochem Pharmacol       Date:  1968-01       Impact factor: 5.858

7.  Acetylator status and response to phenelzine in depressed patients.

Authors:  E C Johnstone; W Marsh
Journal:  Lancet       Date:  1973-03-17       Impact factor: 79.321

8.  Madras study of supervised once-weekly chemotherapy.

Authors:  N K Menon
Journal:  Bull Int Union Tuberc       Date:  1968-12

9.  A rapid accurate procedure for the determination of serotonin in whole human blood.

Authors:  A Yuwiler; S Plotkin; E Geller; E R Ritvo
Journal:  Biochem Med       Date:  1970-04

10.  A clinical trial of phenelzine in anxiety depressive and phobic neuroses.

Authors:  C Q Mountjoy; M Roth; R F Garside; I M Leitch
Journal:  Br J Psychiatry       Date:  1977-11       Impact factor: 9.319

View more
  5 in total

1.  Phenelzine: acetylator status and clinical response.

Authors:  G L Sanders; M D Rawlins
Journal:  Br J Clin Pharmacol       Date:  1979-05       Impact factor: 4.335

Review 2.  Survey of the human acetylator polymorphism in spontaneous disorders.

Authors:  D A Evans
Journal:  J Med Genet       Date:  1984-08       Impact factor: 6.318

3.  Dangerous monoamine oxidase inhibitor interactions are still occurring in the 1990s.

Authors:  J K Dawson; S M Earnshaw; C S Graham
Journal:  J Accid Emerg Med       Date:  1995-03

4.  N2-acetylphenelzine: effects on rat brain GABA, alanine and biogenic amines.

Authors:  K F McKenna; G B Baker; R T Coutts
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-05       Impact factor: 3.000

Review 5.  Genetically determined variability in acetylation and oxidation. Therapeutic implications.

Authors:  D W Clark
Journal:  Drugs       Date:  1985-04       Impact factor: 9.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.